The financial regulations require hedge funds and wealthy investors that exceeded the $100 million equity holdings threshold to file a report that shows their positions at the...
Keep Reading →
May 30 - Hedge Funds, News
Will the new coronavirus cause a recession in US in the next 6 months? On February 27th, we put the probability at 75% and we predicted that the market will decline by at least...
Keep Reading →
May 4 - Hedge Funds, News
Coronavirus is probably the #1 concern in investors' minds right now. It should be.
Keep Reading →
March 12 - News
It is already common knowledge that individual investors do not usually have the necessary resources and abilities to properly research an investment opportunity.
Keep Reading →
December 25 - Hedge Funds, News
We are still in an overall bull market and many stocks that smart money investors were piling into surged through November 22nd.
Keep Reading →
November 28 - Hedge Funds, News
Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first.
Keep Reading →
October 10 - Hedge Funds, News
Investing in hedge funds can bring large profits, but it’s not for everybody, since hedge funds are available only for high-net-worth individuals.
Keep Reading →
June 7 - Hedge Funds, News
Although the masses and most of the financial media blame hedge funds for their exorbitant fee structure and disappointing performance, these investors have proved to have great...
Keep Reading →
March 26 - Hedge Funds, News
With the third-quarter round of 13F filings behind us it is time to take a look at the stocks in which some of the best money managers in the world preferred to invest or sell...
Keep Reading →
December 9 - Hedge Funds, News
We at Insider Monkey have gone over 700 13F filings that hedge funds and prominent investors are required to file by the government.
Keep Reading →
November 13 - Hedge Funds, News
Insiders are masters of snatching up shares of their companies at a discount, expanding their positions during weakness in the stock.
Keep Reading →
June 18 - Insider Trading, Market Movers, News
The five opioid treatment stocks are among several companies that have taken their own approach to the growing opioid addiction market in the US, which also happens to be the...
Keep Reading →
February 5 - Lists, News
The 10 biggest antidepressant drug companies in 2017 are committed to providing the safest and most cost-effective solution for consumers suffering from mental diseases worldwide...
Keep Reading →
December 14 - Lists, News
Curious to know which treatments are among the 15 bestselling most profitable drugs of all time? The pharmaceutical industry has been a topic of interest for investors, market...
Keep Reading →
November 24 - News
Out of hundreds of healthcare stocks that are trading on the U.S stock market, we have selected the top 75 healthcare dividend stocks to invest in.
Keep Reading →
July 17 - Dividend Stocks, News
"U.S. equities rose on Monday as a weekend filled with geopolitical worries ended more calmly than investors expected, while bank stocks charged ahead.
Keep Reading →
April 17 - Commodities, Gold, Market Movers, News, Tech
The 10 least obese countries in the world are mostly from Asia and Africa.
Keep Reading →
March 26 - Lists, News
Detailed results from the IXORA-S study have revealed that Taltz (ixekizumab) has superior efficacy compared to Stelara (ustekinumab).
Keep Reading →
March 8 - News, Stock Analysis
A few weeks ago, President Donald Trump met with a series of biotech CEOs to discuss a historically major pain point for the industry: cutting the FDA drug approval process "at...
Keep Reading →
February 23 - News, Stock Analysis
The once per week Trulicity label from Eli Lilly and Co (NYSE:LLY) has been updated. The changes, which have been approved by the U.S.
Keep Reading →
February 9 - News, Stock Analysis
Acorda Therapeutics Inc (NASDAQ:ACOR) inhaled migraine candidate CVT-427 is seen by Janney analyst Ken Trbovich as likely to give Eli Lilly and Co (NYSE:LLY) severe competition...
Keep Reading →
January 24 - News, Stock Analysis
Eli Lilly and Co (NYSE:LLY) just announced that it is set to acquire junior biotech CoLucid Pharmaceuticals Inc (NASDAQ:CLCD) in a deal worth up to $960 million.
Keep Reading →
January 19 - News, Stock Analysis
The problem of obesity is a modern one, with large sections of the global population becoming overweight late in the 20th century and into the 21st, and the prevalence is especially...
Keep Reading →
January 17 - Lists, News
After a strong 2015, health care stocks are leading the way lower in 2016. And it’s been an even uglier year for biotechnology company Gilead Sciences, Inc.
Keep Reading →
December 23 - News, Stock Analysis
“By diligently prioritizing, we will continue to successfully launch and commercialize new medicines, meet the needs of our customers and patients, and ultimately help AstraZeneca...
Keep Reading →
December 9 - News, Stock Analysis
Eli Lilly and Co (NYSE:LLY) has recently confirmed that it will cut jobs following the release of disappointing results from a clinical trial evaluating solanezumab, affecting...
Keep Reading →
December 8 - News, Stock Analysis
Hedge funds run by legendary names like Nelson Peltz and David Tepper make billions of dollars a year for themselves and their super-rich accredited investors (you’ve got to...
Keep Reading →
November 27 - Hedge Funds, News
As the markets take a break for Thanksgiving, things settled down a little bit late-Wednesday, but not before some sharp shocks in the biotech sector.
Keep Reading →
November 24 - Market Movers, News, Stock Analysis
Biogen Inc (NASDAQ:BIIB) stock is getting whacked in sympathy to Eli Lilly and Co (NYSE:LLY)'s announcement that it has once again failed in its quest to prove solanezumab to ...
Keep Reading →
November 23 - News, Stock Analysis
Eli Lilly And Co (NYSE:LLY) is having an incredibly rough day in the market today.
Keep Reading →
November 23 - News, Stock Analysis
On the day before Thanksgiving, five stocks, First Solar, Inc.
Keep Reading →
November 23 - News
The Humulin R U-500 insulin is prescribed to patients who need a higher dose of insulin on a daily basis.
Keep Reading →
November 10 - News, Stock Analysis
Eli Lilly and Co (NYSE:LLY) has categorically stated to its regulators and investors that it is hanging onto a possible nod from the FDA for a new indication for Jardiance.
Keep Reading →
November 2 - News, Stock Analysis
Although his family office isn't technically a hedge fund anymore (a settlement with the SEC saw to that), many on Wall Street still regard billionaire Steve Cohen's Point72 ...
Keep Reading →
September 19 - Dividend Stocks, Hedge Fund Analysis, Hedge Funds, News
On June 28, 2016, the Endocrinologic and Metabolic Drugs Advisory Committee of the Food and Drug Administration (FDA) met to discuss and vote upon a supplemental New Drug Application...
Keep Reading →
September 9 - News, Stock Analysis
Eli Lilly and Co (NYSE:LLY) is one of the largest drug companies in the world. In this article, we'll take a closer look at why many hedge funds are long the drug company.
Keep Reading →
September 2 - Hedge Funds, News, Stock Analysis
Peter Lynch, the former manager of the Magellan Fund at Fidelity Investments, once said that “Insiders might sell their shares for any number of reasons, but they buy them for...
Keep Reading →
August 17 - Insider Trading, News
Among the stocks traders are talking about are BP plc (ADR) (NYSE:BP), Valero Energy Corporation (NYSE:VLO), CONSOL Energy Inc.
Keep Reading →
July 26 - Earnings Report, News, Tech
Billionaire Andreas Halversen's Viking Global has generated outstanding returns for its investors ever since its inception in 1999, ranking as one of the most successful pure...
Keep Reading →
July 25 - Hedge Fund Analysis, Hedge Funds, News
At the turn of the millennium, the population of the United States clocked in at 282.2 million.
Keep Reading →
June 22 - News, Stock Analysis
Investors have always known that Eli Lilly and Co (NYSE:LLY) has a strong pipeline, but the community didn't know the exact number of potential product launches until now.
Keep Reading →
May 24 - Hedge Funds, News
There's been a slew of earnings reports come in over the past 24 hours, with Procter & Gamble Co (NYSE:PG), 3M Co (NYSE:MMM), E I Du Pont De Nemours And Co (NYSE:DD), Coach Inc...
Keep Reading →
April 26 - Market Movers, News
U.S equities’ awful start to 2016 is gradually getting even worse, which could make investors conclude that the ratio of insider selling to insider buying has dropped significantly...
Keep Reading →
February 9 - Insider Trading, News
In a career spanning over three and a half decades, billionaire Steve Cohen has made a name for himself as being one of the best traders in the world.
Keep Reading →
January 7 - Dividend Stocks, Hedge Funds, News
With the VIX above 20 and many investors on edge over the jump in volatility in recent days, Eli Lilly and Co (NYSE:LLY), Willis Towers Watson (NASDAQ:WLTW), Amazon.com, Inc.
Keep Reading →
January 5 - Market Movers, News, Tech
Is Eli Lilly & Co.
Keep Reading →
December 5 - Hedge Funds, News
Steve Cohen built a strong reputation and personal fortune for himself while managing hedge fund S.A.C Capital Advisors from 1992 until early 2014, when the fund was converted...
Keep Reading →
November 19 - Hedge Fund Analysis, Hedge Funds, News
The week’s trading is underway and several biotech stocks are hot out of the gates, making big early morning gains.
Keep Reading →
October 12 - Hedge Funds, Market Movers, News
Eli Lilly and Co (NYSE:LLY) and Incyte Corporation (NASDAQ:INCY) are experiencing volatility at Tuesday’s open, initially moving in different directions before both started ...
Keep Reading →
September 29 - Market Movers, News